1,720,969 research outputs found

    La gengivite nel bambino e nell’adolescente: una patologia spesso trascurata

    No full text
    Gingivitis is a non-specific inflammatory reaction of the marginal gingiva, which shows a high prevalence in children with a peak around puberty. Several local and systemic factors may determine the inflammatory process, and it has been shown that the dental plaque is a main determinant of gingivitis. Therefore, careful monitoring of dental plaque through daily operations and regular oral hygiene are fundamental to the prevention of gingivitis, as well as a careful evaluation by the Pediatrician in informing parents on the risks of gingivitis and to prevent the occurrence of severe and irreversible forms

    Sindrome da Biberon:Caratteristiche cliniche e prevenzione

    Full text link
    The bottle syndrome represents one of most common cause of caries in childhood. This syndrome is usually due to child’s dietary habits and type of feeding. It is characterized by premature onset involving several dental elements at the same time as well as by severe lesions of the dental tissue. To efficaciously prevent the bottle syndrome is crucial to give a correct information to parents. Pediatrician plays a key role in precocious diagnosis of dental lesions also suggesting a dentistry examination

    Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients.

    No full text
    Although spontaneous remission occurs in patients with idiopathic juvenile osteoporosis (IJO), permanent bone deformities may occur. The effects of long-term pamidronate treatment on clinical findings, bone mineral status, and fracture rate were evaluated. Nine patients (age 9.8 ± 1.1 years, 7 males) with IJO were randomized to intravenous pamidronate (0.8 ± 0.1 mg/kg per day for 3 days; cycles per year 2.0 ± 0.1; duration 7.3 ± 1.1 years; n = 5) or no treatment (n = 4). Fracture rate, phalangeal quantitative ultrasound, and lumbar bone mineral density (BMD) by dual energy X-ray absorptiometry at entry and during follow-up (range 6.3-9.4 years) were assessed. Bone pain improved in treated patients. Difficulty walking continued for 3-5 years in untreated patients, and vertebral collapses occurred in three of them. During follow-up, phalangeal amplitude-dependent speed of sound (AD-SoS), bone transmission time (BTT), and lumbar BMDarea and BMDvolume progressively increased in treated patients (P < 0.05-P < 0.0001). In untreated patients AD-SoS and BTT decreased during the first 2-4 years of follow-up (P < 0.05-P < 0.01); lumbar BMDarea increased after 6 years (P < 0.001) whereas BTT and lumbar BMDvolume increased after 7 years of follow-up (P < 0.05 and P < 0.001, respectively). At the end of follow-up, AD-SoS, BTT, lumbar BMDarea, and BMDvolume Z-scores were lower in untreated patients than in treated patients (-2.2 ± 0.3 and -0.5 ± 0.2; -1.9 ± 0.2 and -0.6 ± 0.2; -2.3 ± 0.3 and -0.7 ± 0.3; -2.4 ± 0.2 and -0.7 ± 0.3, P < 0.0001, respectively). Fracture rate was higher in untreated patients than in treated patients during the first 3 years of follow-up (P < 0.02). Our study showed that spontaneous recovery of bone mineral status is unsatisfactory in patients with IJO. Pamidronate treatment stimulated the onset of recovery phase reducing fracture rate and permanent disabilities without evidence of side-effects
    corecore